Review article: rabeprazole's tolerability profile in clinical trials
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
1999-10-01
Metadata
Show full item recordCitation
Aliment. Pharmacol. Ther. 1999, 13 Suppl 5:17-23Abstract
Rabeprazole is a new member of a class of substituted benzimidazole drugs known as proton pump inhibitors. Comparative trials have demonstrated that it is at least as effective as omeprazole for the treatment of gastrooesophageal reflux disease (GERD), duodenal ulcers, or gastric ulcers. It is significantly more effective than histamine2-receptor antagonists for acid suppression, GERD healing and pain relief, and duodenal ulcer healing and pain relief. Adverse events reported during clinical trials provide an important indication of a medication's tolerability. We demonstrate that rabeprazole has a favourable adverse events profile. It is well tolerated in placebo-controlled studies and comparative trials with omeprazole and H2-receptor antagonists. Moreover, no dose adjustments are required for special populations, such as the elderly or patients with renal or mild-to-moderate hepatic disease. Adverse events data from clinical trials support the use of rabeprazole as a treatment for acid-related diseases.Description
To access publisher full text version of this article. Please click on the hyperlink in Additional Links fieldAdditional Links
http://dx.doi.org/10.1046/j.1365-2036.1999.00035.xae974a485f413a2113503eed53cd6c53
10.1046/j.1365-2036.1999.00035.x
Scopus Count
Collections
Related articles
- Review article: rabeprazole's profile in patients with gastrointestinal diseases.
- Authors: Humphries TJ, Barth J
- Issue date: 1999 Oct
- Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
- Authors: Langtry HD, Markham A
- Issue date: 1999 Oct
- Rabeprazole.
- Authors: Prakash A, Faulds D
- Issue date: 1998 Feb
- Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.
- Authors: Cloud ML, Enas N, Humphries TJ, Bassion S
- Issue date: 1998 May
- Review article: the pharmacology of rabeprazole.
- Authors: Williams MP, Pounder RE
- Issue date: 1999 Aug